Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from 60 Degrees Pharmaceuticals, Inc. ( (SXTP) ) is now available.
On January 20, 2026, 60 Degrees Pharmaceuticals, Inc. received a written notice from the Nasdaq Listing Qualifications Department stating that Nasdaq staff had determined to delist the company’s common stock and warrants from the Nasdaq Capital Market after the shares failed to maintain the required minimum bid price of $1.00 for 30 consecutive business days. Because the company had already executed a 1-for-5 reverse stock split on February 24, 2025, Nasdaq concluded that it was not eligible for the standard 180-day compliance period and is therefore subject to immediate delisting, which also triggers delisting of its warrants since the underlying security would no longer be listed. The company has paid the required fee and requested a hearing to appeal the decision, which temporarily stays any suspension of trading and the formal delisting filing, but there is no assurance that Nasdaq will allow its securities to remain listed, creating uncertainty for shareholders and warrant holders.
The most recent analyst rating on (SXTP) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on 60 Degrees Pharmaceuticals, Inc. stock, see the SXTP Stock Forecast page.
Spark’s Take on SXTP Stock
According to Spark, TipRanks’ AI Analyst, SXTP is a Neutral.
The score is held down primarily by very large ongoing losses and persistent negative free cash flow, which outweigh the recent revenue rebound and low leverage. Technicals are broadly bearish with the stock below key moving averages, while valuation remains unattractive due to lack of profitability. A recent strategy update is modestly positive but paired with explicit going-concern and regulatory risks.
To see Spark’s full report on SXTP stock, click here.
More about 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. is a publicly traded company whose common stock and warrants are listed on the Nasdaq Capital Market, giving it access to public equity markets and a base of exchange-traded investors.
Average Trading Volume: 3,278,286
Technical Sentiment Signal: Sell
Current Market Cap: $2.13M
Find detailed analytics on SXTP stock on TipRanks’ Stock Analysis page.